Effect of Inhaled Albuterol in Pulmonary Hypertension
Status:
Completed
Trial end date:
2020-07-02
Target enrollment:
Participant gender:
Summary
The purpose of the present pilot study is to test the hypothesis that in patients with group
1 pulmonary arterial hypertension (PAH) who are on regular oral pulmonary vasodilator
therapy, inhaled albuterol causes transient pulmonary vasodilation.